Skip to main content

Lymphoma

Open Access Cancer Therapy Review

ADCs in cancer: key data for currently approved agents

Delve into the efficacy and safety data for the antibody–drug conjugates currently approved by the US FDA across tumor types such as hematologic, genitourinary, and gynecologic cancers.

Viruses and hematologic malignancies

Free for a limited time Hematologic Cancer Review

A thorough understanding of the relationship between viruses and hematologic cancers can help clinicians to deliver precise therapies and monitor potential complications.

Doxorubicin use may increase breast cancer risk in adult Hodgkin’s lymphoma survivors

20-03-2024 Hodgkin Lymphoma News

Adolescent and adult survivors of Hodgkin’s lymphoma have a higher risk for developing breast cancer if they receive doxorubicin than if they do not.

Liquid biopsy in T-cell lymphoma

Open Access Lymphoma Review

Tissue biopsy is the gold standard for diagnosis in T-cell lymphoma, but is not always feasible. Could liquid biopsy be used instead, and not just for diagnosis but also for monitoring treatment response?

Primary thyroid lymphoma: a case series

Open Access Thyroid Cancer Case Study

Although rare, primary thyroid lymphoma should be considered in cases of rapidly growing goiters. Timely needle biopsy can avoid unnecessary surgery.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine

Case Studies

Primary thyroid lymphoma: a case series

Open Access Thyroid Cancer Case Study

Although rare, primary thyroid lymphoma should be considered in cases of rapidly growing goiters. Timely needle biopsy can avoid unnecessary surgery.

Obinutuzumab-induced acute thrombocytopenia

Open Access Lymphoma Case Study

A case series of three patients suggests that obinutuzumab-induced acute thrombocytopenia is a frequent, possibly non-relapsing, and unique adverse event that deserves more attention than it currently receives.

Tumor thrombus in a patient with primary adrenal diffuse large B cell lymphoma

Open Access Adrenal Cancer Case Study

This case highlights the need to consider whether a tumor embolism is present in the central adrenal vein, renal vein, or inferior vena cava when a diagnosis of primary adrenal lymphoma is made.

Live Webinar | 10-06-2024 | 16:30 (CEST)

Challenges in advanced CTCL – diagnosis and management

Live: Monday 10 June 2024, from 16:30 – 18:00 (CEST)

In this live interactive webinar, a multidisciplinary team of speakers will provide practical guidance on managing patients with cutaneous T-cell lymphoma. Learn about the key aspects of diagnosis and treatment via a series of patient cases.

Sponsored by: Kyowa Kirin

Developed by: Springer Healthcare

Current Reviews

Optimizing random skin biopsies: a review of techniques and indications for intravascular large B-cell lymphoma

Open Access Lymphoma Review Article

Intravascular large B-cell lymphoma (IVLBCL), a rare subtype of malignant lymphoma, is diagnosed by observation of intravascular proliferation of tumor cells in samples taken from affected organs. However, diagnosis of IVLBCL is usually difficult …

Recent advances in understanding the biology of follicular lymphoma

Lymphoma Progress in Hematology

Follicular lymphoma (FL), the most common indolent B-cell lymphoma, develops over decades before manifesting as overt disease. BCL2 overexpression by t(14;18) confers a survival advantage to B cells during the germinal center reaction, and …

Long-Term Implications of Implant-Based Breast Reconstruction: What You Should Know About Breast Implant Illness and Breast Implant-Associated ALCL

Despite the equivalent survival rates of lumpectomy and radiation versus mastectomy, rates of mastectomy continue to increase. One of the reasons for this rise has been attributed to the improvements in breast reconstruction. Most patients who …

Synchronous Anal Squamous Cell Carcinoma and Diffuse Large B Cell Lymphoma of Stomach: the First Report of an Odd Couple

The unique case study presented here explores an exceptionally rare occurrence in an HIV-positive female—synchronous diagnoses of anal squamous cell carcinoma and diffuse large B cell lymphoma (DLBCL) of the stomach. With limited existing …

Case-Based Insights: Oncology and Hematology (Link opens in a new window)


Refresh your knowledge in Oncology and Hematology: 

  • 45 clinical cases across different topics with relevant clinical images
  • Written by renowned experts 
  • Knowledge-check questions with answers
Try the first set of cases now
SPONSORED

Webinar

A series of patient cases underpin this live interactive webinar that aims to provide practical guidance on a multidisciplinary approach to managing patients with cutaneous T-cell lymphoma.

Sponsored by:
  • Kyowa Kirin
Developed by: Springer Healthcare

Cases

Take on interactive case studies with a focus on hematology. Each case has been prepared by renowned experts in the field and features knowledge-check questions with answers to help keep you and your practice up to date.

Developed by: Springer Medizin

Further Reading

Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomas

Open Access Non-Hodgkin Lymphoma Original Article

The conditioning regimen is an important part of autologous hematopoietic stem cell transplantation (ASCT). We explored the efficacy and safety of an optimized BEAC (adjusted-dose, intermediate-dose cytarabine and reduced-dose cyclophosphamide …

ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression

Open Access Lymphoma Case Report

ALK-positive ( +) large B cell lymphoma (ALK + LBCL) is a rare distinct subtype of diffuse large B cell lymphoma presenting with high stage and aggressive behavior. Although B cell markers such as CD20, CD19, and CD22 are generally negative …

Optimizing random skin biopsies: a review of techniques and indications for intravascular large B-cell lymphoma

Open Access Lymphoma Review Article

Intravascular large B-cell lymphoma (IVLBCL), a rare subtype of malignant lymphoma, is diagnosed by observation of intravascular proliferation of tumor cells in samples taken from affected organs. However, diagnosis of IVLBCL is usually difficult …

Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients

Open Access Lymphoma Original Article

MYC-rearranged B-cell lymphoma (BCL) in the pediatric/young adult (YA) age group differs substantially in disease composition from adult cohorts. However, data regarding the partner genes, concurrent rearrangements, and ultimate diagnoses in these …